Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Celgene Corporation    CELG   US1510201049

CELGENE CORPORATION

 (CELG)

35
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Celgene Corporation : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales3 6204 8425 5076 1497 0428 415
Operating income (EBITDA)1 8472 2432 7363 0223 4964 340
Operating profit (EBIT)1 5882 1722 6512 9693 5164 396
Pre-Tax Profit (EBT)-1 4201 681---
Net income8851 3181 4562 0342 4163 062
EPS ( $)1,882,853,304,685,807,49
Dividend per Share ( $)------
Yield------
Announcement Date01/27/2011
12:30pm
01/26/2012
12:25pm
01/24/2013
12:30pm
---
Finances - Leverage
Celgene Corporation : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt------
Finance1 3548468202 0484 7888 143
Operating income (EBITDA)1 8472 2432 7363 0223 4964 340
Leverage
(Debt/EBITDA)
------
Capital Expenditure98,6132112137150172
Book Value Per Share (BVPS)12,7 $12,6 $13,6 $20,5 $27,4 $38,9 $
Cash Flow per Share2,52 $3,91 $4,58 $6,46 $7,79 $10,5 $
Announcement Date01/27/2011
12:30pm
01/26/2012
12:25pm
01/24/2013
12:30pm
---
Balance Sheet Analysis
Celgene Corporation : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 51 131 M$ -
Company Value 49 082 M$ 46 343 M$
Valuation 2013e 2014e
PER (Price / EPS) 26,2x 21,1x
Capitalization / Revenue 8,32x 7,26x
EV / Revenue 7,98x 6,58x
EV / EBITDA 16,2x 13,3x
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 48,3% 49,9%
operating laverage (Delta EBIT / Delta Sales) 1,03x 1,27x
Net Margin (Net Profit / Revenue) 33,1% 34,3%
ROA (Net Profit / Asset) 18,4% 17,9%
ROE (Net Profit / Equities) 29,7% 26,9%
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   2,23% 2,13%
Cash Flow / Sales (Taux d'autofinancement) 43,8% 46,1%
Capital Intensity (Assets / Sales) 1,80x 1,92x
Financial Leverage (Net Debt / EBITDA) -0,68x -1,37x
Price Earning Ratio
Celgene Corporation : Price Earning Ratio
EPS & Dividend
Celgene Corporation : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.